FDA is warning consumers and healthcare professionals about antimicrobial drugs that are being marketed as dietary supplements.
FDA is warning consumers and healthcare professionals about antimicrobial drugs that are being marketed as dietary supplements.
Several companies, among them Multi-Mex Distributor Inc., are marketing antibiotics, antivirals, and antifungals, primarily to the Hispanic community. The products include Amoxilina Capsules, Amoxilina Suspension, Pentreximil Plus 500 mg, Pentremximil Plus Syrup, and Pentrexyl Forte Natural. They are being distributed in Colorado, Delaware, Texas, Florida, California, Georgia, and potentially other states.
“The FDA is aware of at least 4 cases in Texas where children received emergency care due to worsening illnesses, after being given products that the parents may have believed contained antimicrobials. These products were packaged to resemble antimicrobial drugs that are readily available in Mexico,” according to a statement from FDA.
The supplements are sold by various retailers, including independent stores that cater to Hispanic customers. The package labels are printed in both English and Spanish.
In early May, Multi-Mex Distributor recalled several supplements being marketed as antibiotics, including Amoxilina, Bisolvon Jarabe Adulto, M. Vermex, and Synalar Gotas Nariz.
Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease
December 7th 2023A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.
Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care
December 5th 2023According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.